PRGO - PERRIGO Co plc


11.39
-0.950   -8.341%

Share volume: 6,056,597
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$12.34
-0.95
-0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
38%
Profitability 16%
Dept financing 39%
Liquidity 66%
Performance 53%
Company vs Stock growth
vs
Performance
5 Days
-13.84%
1 Month
-22.57%
3 Months
-15.57%
6 Months
-51.09%
1 Year
-61.11%
2 Year
-56.58%
Key data
Stock price
$11.39
P/E Ratio 
0.00
DAY RANGE
$11.30 - $12.22
EPS 
-$10.29
52 WEEK RANGE
$11.30 - $29.41
52 WEEK CHANGE
-$61.35
MARKET CAP 
1.874 B
YIELD 
8.33%
SHARES OUTSTANDING 
137.649 M
DIVIDEND
$0.29
EX-DIVIDEND DATE
03-02-2026
NEXT EARNINGS DATE
08-01-2025
BETA 
0.35
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,841,897
AVERAGE 30 VOLUME 
$3,025,765
Company detail
CEO: Murray S. Kessler
Region: US
Website: perrigo.com
Employees: 8,900
IPO year: 1991
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being. The company operates through two segments, Consumer Self-Care Americas and Consumer Self Care International. Its products include Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh and Burt's Bees brand names.

Recent news